Dofetilide for the treatment of premature ventricular complexes and ventricular tachycardia in patients with structural heart disease.

Background: Dofetilide is a class III antiarrhythmic agent approved for the treatment of atrial fibrillation and atrial flutter. Given the efficacy of other class III agents, it has been used off‐label for the treatment of premature ventricular complexes (PVCs) and ventricular tachycardias (VTs). Ob...

Full description

Bibliographic Details

Published in:	Journal of Cardiovascular Electrophysiology Vol. 35; no. 12; pp. 2363 - 2372
Main Authors:	Deshmukh, Amrish, Yokokawa, Miki, McBride, Daniel, Simpson, Jamie, Chou, Andrew, Ghannam, Michael, Liang, Jackson J., Saeed, Mohammed, Cunnane, Ryan, Ghanbari, Hamid, Latchamsetty, Rakesh, Crawford, Thomas, Jongnarangsin, Krit, Pelosi, Frank, Chugh, Aman, Morady, Fred, Bogun, Frank, Oral, Hakan
Format:	research tables/charts Journal Article
Published:	Wiley-Blackwell Dec2024
Online Access:	View this record in EBSCOhost